TI
KDNY

Turner Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Turner Investments’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,580
Closed -$806K – 254
2016
Q1 		$806K Buy
+12,580
New +$1.02M 0.22% 129

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Turner Investments's KDNY Position: Q2 2016 in Review

Turner Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2016, closing a stake of 12,580 shares — an estimated $806K sold.

Turner Investments first reported a position in KDNY in Q1 2016 and held it in 1 quarter. The position peaked at $806K in Q1 2016. 102 funds tracked by Wall St. Rank hold KDNY as of Q2 2016.

  • Turner Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Turner Investments sold 12,580 Chinook Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $806K.
  • Turner Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Turner Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $806K in Q1 2016.
  • 102 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Turner Investments's 13F filing for Q2 2016, filed 5 Aug 2016.